Thursday, January 28, 2016

Undertreated HIV and Drug-Resistant Tuberculosis at a Referral Hospital in Irkutsk, Siberia

SETTING:
A referral hospital for tuberculosis (TB) in Irkutsk, the Russian Federation.

OBJECTIVE:
To describe disease characteristics, treatment and hospital outcomes of TB-HIV (human immunodeficiency virus).

DESIGN:
Observational cohort of HIV-infected patients admitted for anti-tuberculosis treatment over 6 months.

RESULTS:
A total of 98 patients were enrolled with a median CD4 count of 147 cells/mm(3) and viral load of 205 943 copies/ml. Among patients with drug susceptibility testing (DST) results, 29 (64%) were multidrug-resistant (MDR), including 12 without previous anti-tuberculosis treatment. Nineteen patients were on antiretroviral therapy (ART) at admission, and 10 (13% ART-naïve) were started during hospitalization. Barriers to timely ART initiation included death, in-patient treatment interruption, and patient refusal. Of 96 evaluable patients, 21 (22%) died, 14 (15%) interrupted treatment, and 10 (10%) showed no microbiological or radiographic improvement. Patients with a cavitary chest X-ray (aOR 7.4, 95%CI 2.3-23.7, P = 0.001) or central nervous system disease (aOR 6.5, 95%CI 1.2-36.1, P = 0.03) were more likely to have one of these poor outcomes.

CONCLUSION:
High rates of MDR-TB, treatment interruption and death were found in an HIV-infected population hospitalized in Irkutsk. There are opportunities for integration of HIV and TB services to overcome barriers to timely ART initiation, increase the use of anti-tuberculosis regimens informed by second-line DST, and strengthen out-patient diagnosis and treatment networks.

Purchase full article at:   http://goo.gl/w3V27c

  • 1Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
  • 2Scientific Centre for Family Health and Human Reproduction Problems, Irkutsk, Russian Federation; Regional TB Prevention Dispensary, Irkutsk, Russian Federation.
  • 3Scientific Centre for Family Health and Human Reproduction Problems, Irkutsk, Russian Federation.
  • 4Regional TB Prevention Dispensary, Irkutsk, Russian Federation; State Medical Continuing Education Academy, Irkutsk, Russian Federation.
  • 5Regional TB Prevention Dispensary, Irkutsk, Russian Federation.
  • 6Scientific Centre for Family Health and Human Reproduction Problems, Irkutsk, Russian Federation; State Medical Continuing Education Academy, Irkutsk, Russian Federation.
  • 7Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
  •  2016 Feb;20(2):187-92. doi: 10.5588/ijtld.14.0961. 




No comments:

Post a Comment